This study evaluated the effects of a combination investigational therapy compared to a placebo when used in addition to your current statin therapy.
The total study participation was approximately 18 weeks.
- Generally healthy; 18-75 years of age
- Had elevated LDL cholesterol
- Were on a stable doses of high-intensity statin (atorvastatin 40 or 80 mg or rosuvastatin 20 or 40 mg)